Evaluation of the Use of Human Papillomavirus Persistence for Determination of the Treatment Efficacy Among Women With Cervical Intraepithelial Neoplasia, and for Prediction of Recurrence of Cervical Disease
Cervical samples for human papillomavirus (HPV) DNA analysis and cytological analysis were
obtained from women with abnormal smears referred to Umeå university hospital, Sweden, for
treatment with conization. These women were scheduled for HPV DNA testing and Pap smears
before and 3, 6, 12, 24 and 36 months after treatment. The HPV DNA testing was performed
with a PCR-based genotyping method.
Observational
Observational Model: Cohort, Time Perspective: Prospective
Anna Söderlund Strand, PhD
Principal Investigator
Dept. medical microbiology, Malmö university hospital, Malmö, Sweden
Sweden: Institutional Review Board
95-240
NCT00931190
February 2001
November 2005
Name | Location |
---|